DALLAS, July 2, 2015 /PRNewswire/ --
According to a new market research report " Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation), Application (Depression, Parkinson's, Tinnitus, Alzheimer's, Epilepsy, Ischemia, Obesity) Trends & Global Forecast to 2020", published by MarketsandMarkets, the global Neuromodulation Market is estimated at $3.65 Billion in 2015, and is projected to reach $6.20 Billion by 2020, at a CAGR of 11.2% during the forecast period.
Browse 84 market data Tables and 32 Figures spread through 182 Pages and in-depth TOC on "Neuromodulation Market"
Early buyers will receive 10% customization on this report.
This report studies the global Neuromodulation Market from 2015 to 2020. The global Neuromodulation Market is segmented on the basis of technology, application, and region.
Based on technology, the Neuromodulation Market is segmented into internal neuromodulation and external neuromodulation. Internal neuromodulation is further segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), and gastric electrical stimulation (GES). External neuromodulation is categorized into transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and respiratory electrical stimulation (RES).
Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=921
Based on application, the Neuromodulation Market is segmented into technology-wise applications, such as spinal cord stimulation (chronic pain, failed back surgery, ischemia); deep brain stimulation (Parkinson's disease, tremor, depression, others); sacral nerve stimulation (urine incontinence, fecal incontinence); vagus nerve stimulation (epilepsy, others); gastric electrical stimulation (gastro paresis, obesity); transcutaneous electrical nerve stimulation (treatment resistant depression, others); and transcranial magnetic stimulation (depression, migraine headaches).
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and rest of the world (RoW). The rest of the world region comprises Latin America, the Middle East, and Africa. North America is expected to account for the largest share of the neuromodulation market, followed by Europe, Asia-Pacific, and rest of the world (RoW) in 2015.
Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by players, and expanded target applications and new indications are driving the growth of this market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals are hindering its market growth.
Some of the major players in the global Neuromodulation Market include Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Synapse Biomedical, Inc. (U.S.), Nevro Corporation (U.S.), Neurosigma, Inc. (U.S.), Neuropace, Inc. (U.S.), Neuronetics, Inc. (U.S.), Cyberonics, Inc. (U.S.), and BioControl Medical (Israel).
Browse Related Reports:
Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets